Floatz logo

Pbi-Shrna™ Ews/Fli1 Type 1 Lipoplex

Ewing Family of Tumors

Gradalis, Inc.nucleic_acidPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Ewing Family of Tumors cohort.

Asset / SponsorPhaseRating
Cixutumumab
National Cancer Institute (NCI)
Phase 2BB
Irinotecan
Gradalis, Inc.
Phase 3BB
Irinotecan
Gradalis, Inc.
Phase 3BB
Eloxatin
National Cancer Institute (NCI)
Phase 2BB
FILGRASTIM
M.D. Anderson Cancer Center
Phase 2B

View all 36 →

Same molecule, other indications

Pbi-Shrna™ Ews/Fli1 Type 1 Lipoplex is also rated in:

rareDormant
CC
Indicative ·
47 / 100
View asset →
Ewing sarcomaDormant
CC
Indicative ·
47 / 100
View asset →
sarcomaDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →